Session Track · IDC 2027

Erythema Infectiosum at IDC 2027

Part of the IDC 2027 scientific program · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Erythema Infectiosum Session

Erythema Infectiosum is a mild viral infection that is more commonly known as the “slapped cheek” syndrome or Fifth Disease due to it being the fifth most common childhood disease. It is caused by human Parvovirus B19, which leads to the characteristic facial rash. Other symptoms usually include a mild fever, headaches, and aching joints in adults but these may be absent in children. It spreads easily from person to person, with the virus being released through coughing and sneezing. A person is most contagious during the early stages of the illness and remains contagious for up to 3 weeks. Most common in children, Erythema Infectiosum is easily identified by the bright red rash which appears the sufferer's cheeks. The rash can sometimes spread to the arms, trunk and legs, becoming more evenly distributed as time PC passes. It fades slowly, usually over the course of around 4 weeks, evolving into a lacy reticulated pattern. The rash is typically one of the last symptoms to occur before the infection resolves. In addition to the rash, some people with Erythema Infectiosum may experience aching and tiredness in their joints. Adults are more likely to experience this symptom than children. If joint pain does occur, it is usually mild and short-lived. Erythema Infectiosum is usually a self-limiting illness and most patients do not require any medical treatment. However, those with pre-existing conditions that make them susceptible to more serious complications may need further medical monitoring. It is important that woman who are pregnant or suspect that they may be pregnant seek medical advice as they are at greater risk of potentially serious complications. In conclusion, Erythema Infectiosum is a common viral infection that is easily spread from person to person. It is typically identified by a bright red rash that appears on the cheeks and in some cases spreads to other areas of the body. Most sufferers will not require medical treatment to recover, however pregnant women and those with pre-existing conditions should seek medical advice.

Featured Speakers — Erythema Infectiosum 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Erythema Infectiosum Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Erythema Infectiosum Conference 2027

Present Your Research

Oral and poster slots for original Erythema Infectiosum work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Erythema Infectiosum research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join IDC 2027 for the Erythema Infectiosum track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Erythema Infectiosum Conference 2027 — FAQs

What is the Erythema Infectiosum track at IDC 2027?

The Erythema Infectiosum track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Erythema Infectiosum. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Erythema Infectiosum sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Erythema Infectiosum are all welcome — whether presenting or attending.

Can I present my research in the Erythema Infectiosum track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Erythema Infectiosum sessions?

Yes. IDC 2027 is a hybrid conference — attend the Erythema Infectiosum track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.